InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Discover the complete record of transactions filed by FLESHNER NEIL E., Directeur Médical. Director active across 1 companies, notably POINT Biopharma Global Inc.. Cumulatively, 3 disclosures have been recorded. Total volume traded: €4m. The latest transaction was filed on 25 May 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations3 total
€4m564,204 shares@ €7.0275100.0% of flow
Common Stock
SEC:0001104659-22-065250:0·
3,587,249 shares
Common Stock
SEC:0001104659-21-087826·
3,587,249 shares
Common Stock
SEC:0001104659-21-087826:0·
3 of 3 declarations
About FLESHNER NEIL E.
Fleshner Neil E. is the Chief Medical Officer at POINT Biopharma Global Inc. In this role, he is responsible for the medical strategy and research initiatives of the company. His expertise in the medical field allows him to lead innovative projects aimed at improving treatments for patients. He plays a key role in the development of new therapies.
